非酒精性脂肪性肝病相关易感基因及其在发病机制中的作用

宣世英; 袁晨; 芦琳琳; 辛永宁

doi:10.3969/j.issn.1001-5256.2016.03.009

非酒精性脂肪性肝病相关易感基因及其在发病机制中的作用

DOI: 10.3969/j.issn.1001-5256.2016.03.009

1. 青岛市市立医院消化科
2. 南京医科大学附属青岛市市立医院消化科
3. 青岛市市立医院中心实验室

详细信息

中图分类号: R575.5
计量
- 文章访问数: 2162
- HTML全文浏览量: 42
- PDF下载量: 1042
- 被引次数: 0
出版历程
- 收稿日期: 2015-11-17
- 出版日期: 2016-03-20

Research advances in susceptibility genes and their role in the pathogenesis of nonalcoholic fatty liver disease

Department of Gastroenterology,Qingdao Municipal Hospital

摘要

摘要: 非酒精性脂肪性肝病（NAFLD）发病率逐年增高并呈低龄化趋势,严重增加个人及社会经济负担。作为一种遗传-代谢-环境相关疾病,遗传因素在NAFLD发生发展中起着尤为重要的作用。随着全基因组关联研究技术的广泛应用,对NAFLD遗传易感基因的研究不断取得新的进展。总结国内外现有研究成果,以其遗传易感基因多态性为切入点,探讨影响NAFLD的发病因素及内在机制。
- 脂肪肝 /
- 疾病遗传易感性 /
- 多态性,单核苷酸
Abstract: Currently the incidence of nonalcoholic fatty liver disease( NAFLD) is increasing,and the age of onset is getting younger worldwide,resulting in a heavy economic burden for both individuals and the society. Since NAFLD is closely related to heredity,metabolism,and the environment,genetic factors play an important role in the development and progression of NAFLD. With the development and wide application of the techniques from the genome- wide association studies,new research advances have been achieved in the susceptibility genes of NAFLD. This review summarizes the related research findings at home and abroad,and investigates the pathogenic factors for NAFLD and related mechanisms with a focus on the polymorphisms of susceptibility genes.
- fatty liver /
- genctic predisposition to disease /
- polymorphism,single nucleotide

HTML全文

参考文献(61)

[1]GRANDONE A,MARZUILLO P,PERRONE L,et al.Iron metabolism dysregulation and cognitive dysfunction in pediatric obesity:is there a connection?[J].Nutrients,2015,7(11):9163-9170.

[2]DAY CP.NASH-related liver failure:one hit too many?[J].Am J Gastroenterol,2002,97(8):1872-1874.

[3]TILG H,MOSCHEN AR.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology,2010,52(5):1836-1846.

[4]ZHANG CX,GUO LK,GUO XF.Interaction of polymorphisms of Leptin receptor gene Gln223Arg,Mn SOD9Ala/Val genes and smoking in nonalcoholic fatty liver disease[J].J Hygiene Res,2014,43(5):724-731.(in Chinese)张超贤,郭李柯,郭晓凤.瘦素受体基因Gln223Arg、锰超氧化物歧化酶9Ala/Val基因多态性与吸烟的交互作用和非酒精性脂肪性肝病关系[J].卫生研究,2014,43(5):724-731.

[5]SWELLAM M,HAMDY N.Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor[J].IUBMB Life,2012,64(2):180-186.

[6]LU H,SUN J,SUN L,et al.Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China[J].J Gastroenterol Hepatol,2009,24(2):228-232.

[7]ZAIN SM,MOHAMED R,MAHADEVA S,et al.A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease[J].Hum Genet,2012,131(7):1145-1152.

[8]LI YL,YANG M,MENG XD,et al.The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease[J].Chin J Hepatol,2010,18(6):459-462.(in Chinese)李异玲,杨淼,孟晓丹,等.非酒精性脂肪性肝病患者血清瘦素和脂联素与胰岛素抵抗的关系[J].中华肝脏病杂志,2010,18(6):459-462.

[9]GUPTA AC,MISRA R,SAKHUJA P,et al.Association of adiponectin gene functional polymorphisms(-11377C/G and+45T/G)with nonalcoholic fatty liver disease[J].Gene,2012,496(1):63-67.

[10]MENTA A,MEYRE D,LANKTREE MB,et al.Causal relationship between adiponectin and metabolic traits:a Mendelian randomization study in a multiethnic population[J].PLo S One,2013,8(6):e66808.

[11]HASHEMI M,HANAFI BOJD H,ESKANDARI NASAB E,et al.Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease[J].Hepat Mon,2013,13(5):e9527.

[12]GU YJ,WANG Q.Relationship of adiponectin receptor gene polymorphisms with nonalcoholic fatty liver disease[J].Chin J Dig,2011,31(5):343-344.(in Chinese)古艳芳,王琦.脂联素受体基因多态性与非酒精性脂肪性肝病的关系[J].中华消化杂志,2011,31(5):343-344.

[13]HUANG Q,YANG TL,TANG BS,et al.Two novel functional single nucleotide polymorphisms of ADRB3 are associated with type 2diabetes in the Chinese population[J].J Clin Endocrinol Metab,2013,98(7):e1272-e1277.

[14]ZHANG CX,GUO LK,GUO XF.Correlation of cigarette smoking and the polymorphisms ofβ3-adrenergic receptor gene Trp64Arg,MnSOD9Ala/Val genes with nonalcoholic fatty liver disease[J].J Xi'an Jiaotong Univ:Med Sci,2015,36(1):106-121.(in Chinese)张超贤,郭李柯,郭晓凤.吸烟和β3-肾上腺素能受体基因Trp64Arg、锰超氧化物歧化酶9Ala/Val基因多态性与非酒精性脂肪性肝病的相关性[J].西安交通大学学报:医学版,2015,36(1):106-121.

[15]PETERSEN KF,DUFOUR S,HARIRI A,et al.Apolipoprotein C3gene variants in nonalcoholic fatty liver disease[J].N Engl J Med,2010,362(12):1082-1089.

[16]NIU TH,JIANG M,LIU HG,et al.Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease[J].Chin J Hepatol,2014,22(5):374-379.(in Chinese)牛同红,姜曼,刘昊刚,等.载脂蛋白C3启动子区基因多态性与非酒精性脂肪性肝病的相关性[J].中华肝脏病杂志,2014,22(5):374-379.

[17]POLLEX RL,BAN MR,YOUNG TK,et al.Association between the-455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample[J].BMC Med Genet,2007,8:80.

[18]VALENTI L,NOBILI V,AL-SERRIl A,et al.The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3I148M genotype in patients with nonalcoholic fatty liver[J].J Hepatol,2011,55(6):1409-1414.

[19]NIU TH,JIANG M,XIN YN,et al.Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population[J].World J Gastroenterol,2014,20(13):3655-3662.

[20]VERRIJKEN A,BECKERS S,FRANCQUE S,et al.A gene variant of PNPLA3,but not of APOC3,is associated with histological parameters of NAFLD in an obese population[J].Obesity(Silver Spring),2013,21(10):2138-2145.

[21]HYYSALO J,STOJKOVIC I,KOTRONEN A,et al.Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol,2012,27(5):951-956.

[22]SENTINELLI F,ROMEO S,MAGLIO C,et al.Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis,lipid profile and insulin resistance in obese Southern Europeans[J].Lipids Health Dis,2011,10:93.

[23] ZHANG H,CHEN L,XIN Y,et al.Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease:a meta-analysis[J].Hepat Mon,2014,14(10):e23100.

[24]PUPPALA J,BHRUGUMALLA S,KUMAR A,et al.Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease[J].Indian J Gastroenterol,2014,33(6):524-529.

[25]JIANG X,BAI XY,WU HJ.Role of peroxisome proliferator-activated receptors in the pathogenesis of nonalcoholic fatty liver disease[J].Progr physiolog Sci,2015,46(3):220-226.(in Chinese)姜潇,白晓彦,伍会健.PPARs在非酒精性脂肪性肝病发病机制中的作用[J].生理科学进展,2015,46(3):220-226.

[26]CHEN S,LI Y,LI S,et al.A Val227Ala substitution in the peroxisome proliferator activated receptor alpha(PPAR alpha)gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio[J].J Gastroenterol Hepatol,2008,23(9):1415-1418.

[27]DONGIOVANNI P,RAMETTA R,FRACANZANI AL,et al.Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease:a case control study[J].BMC Gastroenterol,2010,10:102.

[28]ROMEO S,KOZLITINA J,XING C,et al.Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease[J].Nat Genet,2008,40(12):1461-1465.

[29] ZHANG DD,JIANG M,YIN YN,et al.Construction of lentivirus vectors containing PNPLA3 gene and overexpression of PNPLA3 in Huh-7 cells[J].Chin J Hepatol,2013,21(3):236-238.(in Chinese)张丁丁,姜曼,辛永宁,等.PNPLA3 rs738409基因多态性与非酒精性脂肪性肝病遗传易感性的关系[J].中华肝脏病杂志,2013,21(3):236-238.

[30]XU J,XIN YN,LYU WH,et al.Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease[J].Chin J Hepatol,2013,21(8):619-623.徐静,辛永宁,吕维红,等.PNPLA3 rs738409基因多态性与非酒精性脂肪性肝病遗传易感性的关系[J].中华肝脏病杂志,2013,21(8):619-623.

[31]MARZUILLO P,GRANDONE A,PERRONE L,et al.Weight loss allows the dissection of the interaction between abdominal fat and PNPLA3(adiponutrin)in the liver damage of obese children[J].J Hepatol,2013,59(5):1143-1144.

[32]MAHDESSIAN H,TAXIARCHIS A,POPOV S,et al.TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content[J].Proc Natl Acad Sci U S A,2014,111(24):8913-8918.

[33]KOZLITINA J,SMAGRIS E,STENDER S,et al.Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease[J].Nat Genet,2014,46(4):352-356.

[34]PIROLA CJ,SOOKOIAN S.The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver:a Meta-analysis[J].Hepatology,2015,62(6):1742-1756.

[35]LI L,WANG SJ,SHI K,et al.Correlation between MTP-493G>T polymorphism and non-alcoholic fatty liver disease risk:a Meta-analysis[J].Genet Mol Res,2014,13(4):10150-10161.

[36]PENG XE,WU YL,LU QQ,et al.MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population[J].Liver Int,2014,34(1):118-128.

[37]MEHTA R,BIRERDINC A,YOUNOSSI ZM.Host genetic variants in obesity-related nonalcoholic fatty liver disease[J].Clin Liver Dis,2014,18(1):249-267.

[38]OTT C,ROSS K,STRAUB S,et al.Sam50 functions in mitochondrial intermembrane space bridging and biogenesis of respiratory complexes[J].Mol Cell Biol,2012,32(6):1173-1188.

[39]OTT C,DORSCH E,FRAUNHOLZ M,et al.Detailed analysis of the human mitochondrial contact site complex indicate a hierarchy of subunits[J].PLo S One,2015,10(3):e0120213.

[40]KITAMOTO T,KITAMOTO A,YONEDA M,et al.Genome-wide scan revealed that polymorphisms in the PNPLA3,SAMM50,and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan[J].Hum Genet,2013,132(7):783-792.

[41]BEER NL,TRIBBLE ND,MCCULLOCH LJ,et al.The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver[J].Hum Mol Genet,2009,18(21):4081-4088.

[42]SPELIOTES EK,YERGES-ARMSTRONG LM,WU J,et al.Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits[J].PLo S Genet,2011,7(3):e1001324.

[43]BAI LM,MA YZ,WANG QL.Research advances in the roles of TNF-αand leptin in the development and progression of nonalcoholic fatty liver disease[J].Inner Mongolia J Tradit Chin Med,2012,44(9):1086-1089.(in Chinese)白莲梅,马玉珍,王清莲.TNF-α瘦素与非酒精性脂肪性肝病发生发展相关性的研究进展[J].内蒙古医学杂志,2012,44(9):1086-1089.

[44]NADERI M,YAGHOOTKAR H,TARA F,et al.Tumor necrosis factor-alpha polymorphism at position-238 in preeclampsia[J].Iran Red Crescent Med J,2014,16(1):e11195.

[45]LIN X,ZHANG Z,CHEN JM,et al.Role of APN and TNF-alpha in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease[J].Genet Mol Res,2015,14(2):2940-2946.

[46]PURNOMO HD,MUNDHOFIR FE,KASNO,et al.Combination of aspartate aminotranferase and tumor necrosis factor-alpha as non invasive diagnostic tools for non alcoholic steatohepatitis(NASH)[J].Acta Med Indones,2015,47(1):16-23.

[47]WANG JK,FENG ZW,LI YC,et al.Association of tumor necrosis factor-alpha gene promoter polymorphism at sites-308 and-238with non-alcoholic fatty liver disease:a meta-analysis[J].J Gastroenterol Hepatol,2012,27(4):670-676.

[48]CHU H,YANG J,MI S,et al.Tumor necrosis factor-alpha G-308 A polymorphism and risk of coronary heart disease and myocardial infarction:a case-control study and Meta-analysis[J].J Cardiovasc Dis Res,2012,3(2):84-90.

[49]TOKUSHIGE K,TAKAHURA M,TSUCHIYA-MATSUSHITA N,et al.Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis[J].J Hepatol,2007,46(6):1104-1110.

[50]VALENTI L,FRACANZANI AL,DONGIOVANNI P,et al.Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease[J].Gastroenterology,2002,122(2):274-280.

[51]CHENG Y,AN B,JIANG M,et al.Association of tumor necrosis factor-alpha polymorphisms and risk of coronary artery disease in patients with non-alcoholic fatty liver disease[J].Hepat Mon,2015,15(3):e26818.

[52]MAHMOUD AA,BAKIR AS,SHABANA SS.Serum TGF-beta,Serum MMP-1,and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD[J].Saudi J Gastroenterol,2012,18(5):327-333.

[53]ZAIN SM,MOHANED Z,MAHADEVA S,et al.Susceptibility and gene interaction study of the angiotensin II type 1 receptor(AGTR1)gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population[J].PLo S One,2013,8(3):e58538.

[54]SAZCI A,ERGUL E,AYGUN C,et al.Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis(NASH)[J].Cell Biochem Funct,2008,26(3):291-296.

[55]WILLEBRORDS J,PEREIRA IV,MAES M,et al.Strategies,models and biomarkers in experimental non-alcoholic fatty liver disease research[J].Prog Lipid Res,2015,59:106-125.

[56]NUSSBAUM JM,LIU LJ,HASAN SA,et al.Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis[J].Hepatology,2013,58(4):1326-1338.

[57]HSU CC,PAI WY,LAI CY,et al.Genetic characterization and in vivo image analysis of novel zebrafish Danio rerio pigment mutants[J].J Fish Biol,2013,82(5):1671-1683.

[58]HER GM,PAI WY,LAI CY,et al.Ubiquitous transcription factor YY1 promotes zebrafish liver steatosis and lipotoxicity by inhibiting CHOP-10 expression[J].Biochim Biophys Acta,2013,1831(6):1037-1051.

[59]THAKUR PC,STUCKENHOLZ C,RIVERA MR,et al.Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish[J].Hepatology,2011,54(2):452-462.

[60]SHARMA M,MITNALA S,VISHNUBHOTLA RK,et al.The riddle of nonalcoholic fatty liver disease:progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis[J].J Clin Exp Hepatol,2015,5(2):147-158.

[61]WAN X,XU C,YU C.Role of the NLRP3 inflammasome in the progression of nonalcoholic fatty liver disease to nonalcoholic steatohepatitis[J].Can J Gastroenterol Hepatol,2015.[Epub ahead of print]

施引文献

资源附件(0)

访问统计